Congratulations to miRoncol, which received a 2024 Breakthrough Merit and Abstract Award for its Abstract Presentation entitled: “Machine learning-based noninvasive diagnostic classifiers for the prediction of cancer tissue of origin using serum microRNAs.” miRoncol’s poster presentation at ASCO Breakthrough 2024 was acknowledged by Conquer Cancer, the ASCO Foundation as 2024 Breakthrough Abstract Awards! The awards “support the first authors of the 39 highest-rated abstracts selected for presentation during ASCO Breakthrough”.
Check out the official press release from Conquer Cancer here:
The abstract and poster for miRoncol’s presentation at the 2024 ASCO Breakthrough are directly available from the conference website. Citation: J Clin Oncol 42, 2024 (suppl 23; abstr 101)